目的：了解川北医学院附属医院（以下简称“我院”）肿瘤科住院患者使用麻醉药品的情况。方法：采用回顾性调查方法，调取2013—2015年我院肿瘤科住院患者使用麻醉药品的数据，对药品用量、销售金额、用药频度、排序比（药品销售金额排序／用药频度排序）等进行统计分析。结果：2013—2015年我院住院癌性疼痛患者使用的麻醉药品中，吗啡缓释片最常用，且其用量与销售金额逐年增加；盐酸吗啡缓释片的用药频度和销售金额最高，分别为12550.4和214952.8元，其限定日费用为17.1元；除芬太尼透皮贴与盐酸吗啡注射液外，其余药品的排序比均＞1.0。结论：我院肿瘤科住院患者麻醉药品的使用基本合理，以吗啡缓释片为主，符合《癌症疼痛诊疗规范（2011年版）》的要求。%OBJECTIVE:To investigate the application status of narcotic drugs for inpatients with cancer pain in Affiliated Hospital of North Sichuan Medical College ( hereinafter referred to as “our hospital”) .METHODS: By retrospective investigation method , the application data of narcotic drugs for inpatients with cancer pain in our hospital during 2013-2015 were extracted.Statistical analysis was conducted on the consumption amount , consumption sum , defined daily dose system(DDDs) and ranking ratio(consumption sum ranking/DDDs ranking).RESULTS:Of all the narcotic drugs for inpatients with cancer pain in our hospital during 2013-2015, Morphine sustained-release tablets took the lead of usage frequency , and the usage and consumption sum were in a increasing tread . The DDDs and consumption sum of Morphine hydrochloride sustained release tablets took the lead , respectively 12 550.4 yuan and 214 952.8 yuan, the DDC was 17.1 yuan.Except for fentanyl transdermal system and Morphine hydrochloride injections, the ranking ratio of other drugs were >1.0.CONCLUSIONS: The application of narcotic drugs for inpatients with cancer pain was basically rational , Morphine sustained-release tablets is the predominant drugs which is in line with the requirements of Standard of Diagnosis and Treatment of Cancer Pain (2011).
展开▼
